SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
bph12440-sup-0001-si.doc75K

Figure S1 Changes in anti-HCV activity of IFN-α or other viral enzyme inhibitors in combination with andrographolide. According to the analysis of drug synergism described in Methods section, the antiviral efficacy of each anti-HCV drug in combination with andrographolide at 2.5, 5.0 or 7.5 μM was presented as the fold change in EC90 value relative to the andrographolide-untreated control (defined as 1). The experiments were performed in triplicate, and error bars indicate mean ± SD.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.